Table 2.
The prevalence of physiological symptoms between elite athletes and recreational athletes
| Elite athletes (n = 52) |
Recreational athletes (n = 114) |
χ2 | P-value | |
|---|---|---|---|---|
| %(n) | %(n) | |||
| LEA risk | 55.8 (29) | 35.1 (40) | 6.289 | 0.012* |
| ED risk | 51.9 (27) | 59.6 (68) | 0.871 | 0.351 |
| Underweight | 44.2 (23) | 30.7 (35) | 2.875 | 0.090 |
| Injury | 30.8 (16) | 23.7 (27) | 0.934 | 0.334 |
| Gastrointestinal dysfunction | 50.0 (26) | 59.6 (68) | 1.354 | 0.245 |
| Menstrual disturbance | 67.3 (35) | 43.9 (50) | 7.858 | 0.005** |
| Primary amenorrhea | 53.8 (28) | 13.2 (15) | 30.802 | < 0.001** |
| Secondary amenorrhea | 30.8 (16) | 24.6 (28) | .706 | 0.401 |
| Oligomenorrhea | 13.5 (7) | 13.2 (15) | .003 | 0.957 |
LEA low energy availability, ED eating disorder
∗P-value < 0.05.∗∗P-value < 0.01